Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines.

Wong C, Zhang S, Adam E, Paszat L, Butel JS.

J Infect. 2019 Jun;78(6):476-483. doi: 10.1016/j.jinf.2019.04.007. Epub 2019 Apr 6.

PMID:
30965068
2.

Viral microRNA effects on persistent infection of human lymphoid cells by polyomavirus SV40.

McNees AL, Harrigal LJ, Kelly A, Minard CG, Wong C, Butel JS.

PLoS One. 2018 Feb 12;13(2):e0192799. doi: 10.1371/journal.pone.0192799. eCollection 2018.

3.

Fecal Polyomavirus Excretion in Infancy.

Vanchiere JA, Carillo B, Morrow AL, Jiang X, Ruiz-Palacios GM, Butel JS.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):210-3. doi: 10.1093/jpids/piu101. Epub 2014 Oct 15.

4.

Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.

Tognon M, Corallini A, Manfrini M, Taronna A, Butel JS, Pietrobon S, Trevisiol L, Bononi I, Vaccher E, Barbanti-Brodano G, Martini F, Mazzoni E.

PLoS One. 2016 Jan 5;11(1):e0145720. doi: 10.1371/journal.pone.0145720. eCollection 2016.

5.

Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy.

Comar M, Wong C, Tognon M, Butel JS.

PLoS One. 2014 Oct 21;9(10):e110700. doi: 10.1371/journal.pone.0110700. eCollection 2014.

6.

Complete genomic sequence of a new Human polyomavirus 9 strain with an altered noncoding control region.

Lednicky JA, Butel JS, Luetke MC, Loeb JC.

Virus Genes. 2014 Dec;49(3):490-2. doi: 10.1007/s11262-014-1119-z. Epub 2014 Sep 27.

PMID:
25260554
7.

Naturally arising strains of polyomaviruses with severely attenuated microRNA expression.

Chen CJ, Burke JM, Kincaid RP, Azarm KD, Mireles N, Butel JS, Sullivan CS.

J Virol. 2014 Nov;88(21):12683-93. doi: 10.1128/JVI.01933-14. Epub 2014 Aug 20.

8.

Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters.

Zhang S, Sroller V, Zanwar P, Chen CJ, Halvorson SJ, Ajami NJ, Hecksel CW, Swain JL, Wong C, Sullivan CS, Butel JS.

PLoS Pathog. 2014 Feb 6;10(2):e1003912. doi: 10.1371/journal.ppat.1003912. eCollection 2014 Feb.

9.

Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?

Jasani B, Butel JS.

Leuk Res. 2013 Jun;37(6):607-8. doi: 10.1016/j.leukres.2013.03.008. Epub 2013 Apr 16. No abstract available.

PMID:
23601746
10.

Effects of route of inoculation and viral genetic variation on antibody responses to polyomavirus SV40 in Syrian golden hamsters.

Swain JL, Sroller V, Wong C, Zhang S, Halvorson SJ, Herron AJ, Kozinetz CA, Butel JS.

Comp Med. 2012 Oct;62(5):400-8.

11.

Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas.

Wong C, Vilchez RA, Quiroz J, Adam E, Butel JS.

J Infect. 2013 Jan;66(1):67-74. doi: 10.1016/j.jinf.2012.08.014. Epub 2012 Aug 30.

12.

The diversity of human cancer viruses.

Butel JS, Fan H.

Curr Opin Virol. 2012 Aug;2(4):449-52. doi: 10.1016/j.coviro.2012.07.002. Epub 2012 Jul 20. No abstract available.

PMID:
22819022
13.

Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Kusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, Butel JS.

J Infect Dis. 2012 Sep 15;206(6):875-80. doi: 10.1093/infdis/jis469. Epub 2012 Jul 16.

14.

Patterns of polyomavirus SV40 infections and associated cancers in humans: a model.

Butel JS.

Curr Opin Virol. 2012 Aug;2(4):508-14. doi: 10.1016/j.coviro.2012.06.004. Epub 2012 Jul 6. Review.

15.

Papovaviruses.

Butel JS.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 66.

16.

Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada.

Toracchio S, Foyle A, Sroller V, Reed JA, Wu J, Kozinetz CA, Butel JS.

Emerg Infect Dis. 2010 Nov;16(11):1702-9. doi: 10.3201/eid1611.100628.

17.

A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient.

Broekema NM, Abend JR, Bennett SM, Butel JS, Vanchiere JA, Imperiale MJ.

Virology. 2010 Nov 25;407(2):368-73. doi: 10.1016/j.virol.2010.08.032. Epub 2010 Sep 24.

18.

Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation.

Thomas LD, Milstone AP, Vilchez RA, Zanwar P, Butel JS, Dummer JS.

Transplantation. 2009 Aug 15;88(3):360-6. doi: 10.1097/TP.0b013e3181ae5ff9.

19.

Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX.

Toracchio S, Kozinetz CA, Killen DE, Sheehan AM, Banez EI, Ittmann MM, Sroller V, Butel JS.

J Clin Virol. 2009 Oct;46(2):154-60. doi: 10.1016/j.jcv.2009.06.023. Epub 2009 Jul 23.

20.

Polyomavirus shedding in the stool of healthy adults.

Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS.

J Clin Microbiol. 2009 Aug;47(8):2388-91. doi: 10.1128/JCM.02472-08. Epub 2009 Jun 3.

21.

Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines.

Shearer WT, Ochs HD, Lee BN, Cohen EN, Reuben JM, Cheng I, Thompson B, Butel JS, Blancher A, Abbal M, Aviles H, Sonnenfeld G.

J Allergy Clin Immunol. 2009 Apr;123(4):900-5. doi: 10.1016/j.jaci.2008.12.016. Epub 2009 Feb 20.

PMID:
19232702
22.

Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Patel NC, Halvorson SJ, Sroller V, Arrington AS, Wong C, Smith EO, Vilchez RA, Butel JS.

Virology. 2009 Mar 30;386(1):94-101. doi: 10.1016/j.virol.2008.12.040. Epub 2009 Jan 31.

23.

SV40 lymphomagenesis in Syrian golden hamsters.

McNees AL, Vilchez RA, Heard TC, Sroller V, Wong C, Herron AJ, Hamilton MJ, Davis WC, Butel JS.

Virology. 2009 Feb 5;384(1):114-24. doi: 10.1016/j.virol.2008.10.035. Epub 2008 Nov 28.

24.

The history of tumor virology.

Javier RT, Butel JS.

Cancer Res. 2008 Oct 1;68(19):7693-706. doi: 10.1158/0008-5472.CAN-08-3301. Review.

25.

Detection of polyomavirus SV40 in tonsils from immunocompetent children.

Patel NC, Vilchez RA, Killen DE, Zanwar P, Sroller V, Eldin KW, López-Terrada D, Butel JS.

J Clin Virol. 2008 Sep;43(1):66-72. doi: 10.1016/j.jcv.2008.04.011. Epub 2008 Jun 9.

26.

Evidence of simian virus 40 exposure in a colony of captive baboons.

Westfall LW, Shearer MH, Jumper CA, White GL, Papin JF, Eberle R, Butel JS, Bright RK, Kennedy RC.

Virology. 2008 Jul 20;377(1):54-62. doi: 10.1016/j.virol.2008.03.035. Epub 2008 May 16.

27.

Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters.

Sroller V, Vilchez RA, Stewart AR, Wong C, Butel JS.

J Virol. 2008 Jan;82(2):871-9. Epub 2007 Oct 31.

28.

SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma.

Comar M, Rizzardi C, de Zotti R, Melato M, Bovenzi M, Butel JS, Campello C.

Cancer Res. 2007 Sep 15;67(18):8456-9.

29.

Polyomavirus SV40 and AIDS-related systemic non-Hodgkin's lymphoma.

Vilchez RA, Butel JS.

Cancer Treat Res. 2007;133:215-40. Review. No abstract available.

PMID:
17672043
30.

A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients.

Thomas LD, Vilchez RA, White ZS, Zanwar P, Milstone AP, Butel JS, Dummer S.

J Infect Dis. 2007 Feb 1;195(3):442-9. Epub 2006 Dec 22.

PMID:
17205484
31.

Lymphoproliferative disorders in Costa Rica and simian virus 40.

Meneses A, Lopez-Terrada D, Zanwar P, Killen DE, Monterroso V, Butel JS, Vilchez RA.

Haematologica. 2005 Dec;90(12):1635-42.

32.

Quantification of vertical transmission of Murine polyoma virus by real-time quantitative PCR.

Zhang S, McNees AL, Butel JS.

J Gen Virol. 2005 Oct;86(Pt 10):2721-9.

PMID:
16186225
33.

Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma.

Vilchez RA, Lopez-Terrada D, Middleton JR, Finch CJ, Killen DE, Zanwar P, Jorgensen JL, Butel JS.

Virology. 2005 Nov 10;342(1):38-46. Epub 2005 Aug 24.

34.

Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR.

McNees AL, White ZS, Zanwar P, Vilchez RA, Butel JS.

J Clin Virol. 2005 Sep;34(1):52-62.

PMID:
16087125
35.

Frequent detection of polyomaviruses in stool samples from hospitalized children.

Vanchiere JA, Nicome RK, Greer JM, Demmler GJ, Butel JS.

J Infect Dis. 2005 Aug 15;192(4):658-64. Epub 2005 Jul 12.

36.

Effects of radiation and latent virus on immune responses in a space flight model.

Shearer WT, Zhang S, Reuben JM, Lee BN, Butel JS.

J Allergy Clin Immunol. 2005 Jun;115(6):1297-303.

PMID:
15940150
37.

Polyomavirus SV40 infections in Kazakhstan.

Nurgalieva ZZ, Wong C, Zhangabylov AK, Omarbekova ZE, Graham DY, Vilchez RA, Butel JS.

J Infect. 2005 Feb;50(2):142-8.

PMID:
15667916
38.

Detection of BK virus and simian virus 40 in the urine of healthy children.

Vanchiere JA, White ZS, Butel JS.

J Med Virol. 2005 Mar;75(3):447-54.

PMID:
15648074
39.

Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters.

Vilchez RA, Brayton CF, Wong C, Zanwar P, Killen DE, Jorgensen JL, Butel JS.

Virology. 2004 Dec 5;330(1):168-77.

40.

Phylogenetic analysis of polyomavirus simian virus 40 from monkeys and humans reveals genetic variation.

Forsman ZH, Lednicky JA, Fox GE, Willson RC, White ZS, Halvorson SJ, Wong C, Lewis AM Jr, Butel JS.

J Virol. 2004 Sep;78(17):9306-16.

41.

Emergent human pathogen simian virus 40 and its role in cancer.

Vilchez RA, Butel JS.

Clin Microbiol Rev. 2004 Jul;17(3):495-508, table of contents. Review.

42.

Association between SV40 and non-Hodgkin's lymphoma.

Butel JS, Vilchez RA, Jorgensen JL, Kozinetz CA.

Leuk Lymphoma. 2003;44 Suppl 3:S33-9. Review.

PMID:
15202523
43.

Re: Lack of serologic evidence for prevalent simian virus 40 infection in humans.

Vilchez RA, Butel JS.

J Natl Cancer Inst. 2004 Apr 21;96(8):633; author reply 633-4. No abstract available.

PMID:
15100343
44.

Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient.

Milstone A, Vilchez RA, Geiger X, Fogo AB, Butel JS, Dummer S.

Transplantation. 2004 Apr 15;77(7):1019-24.

PMID:
15087764
45.

An overview of the biology and viral pathogenesis of lymphoproliferative disorders in HIV-infected patients.

Vilchez RA, Butel JS.

Res Initiat Treat Action. 2003 Summer;9(1):14-8. No abstract available.

PMID:
14971361
46.

SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus.

Arrington AS, Moore MS, Butel JS.

Oncogene. 2004 Mar 18;23(12):2231-5.

PMID:
14676832
47.

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.

Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, Visnegarwala F, Lewis DE, Butel JS.

Clin Infect Dis. 2003 Nov 1;37(9):1244-9. Epub 2003 Sep 23.

PMID:
14557970
48.

Polyomavirus SV40 infection and lymphomas in Spain.

Vilchez RA, Butel JS.

Int J Cancer. 2003 Nov 10;107(3):505-6; author reply 507-8. No abstract available.

49.

Re: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.

Vilchez RA, Arrington AS, Butel JS.

J Natl Cancer Inst. 2003 Aug 20;95(16):1249; author reply 1250. No abstract available.

PMID:
12928352
50.

SV40 in human brain cancers and non-Hodgkin's lymphoma.

Vilchez RA, Butel JS.

Oncogene. 2003 Aug 11;22(33):5164-72. Review.

PMID:
12910253

Supplemental Content

Loading ...
Support Center